JFS Wealth Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2
Closed -$50 2031
2024
Q1
$50 Sell
2
-2
-50% -$59 ﹤0.01% 1978
2023
Q4
$146 Hold
4
﹤0.01% 1931
2023
Q3
$193 Hold
4
﹤0.01% 1868
2023
Q2
$274 Sell
4
-2
-33% -$129 ﹤0.01% 1840
2023
Q1
$291 Sell
6
-1
-14% -$53 ﹤0.01% 1786
2022
Q4
$422 Buy
7
+3
+75% +$176 ﹤0.01% 1756
2022
Q3
$0 Buy
4
+1
+33% +$32 ﹤0.01% 1884
2022
Q2
$0 Hold
3
﹤0.01% 1896
2022
Q1
$0 Buy
+3
New +$108 ﹤0.01% 1935
2016
Q3
Sell
-23
Closed -$1K 509
2016
Q2
$1K Buy
+23
New +$1K ﹤0.01% 481

Other funds holding PRTA

JFS Wealth Advisors's PRTA Position: Q2 2024 in Review

JFS Wealth Advisors sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 2 shares — an estimated $50 sold.

JFS Wealth Advisors first reported a position in PRTA in Q2 2016 and held it in 10 quarters. The position peaked at $1K in Q2 2016. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • JFS Wealth Advisors reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • JFS Wealth Advisors sold 2 Prothena Corp shares in Q2 2024, an estimated $50.
  • JFS Wealth Advisors first reported a position in Prothena Corp in Q2 2016 and held it in 10 quarters.
  • JFS Wealth Advisors's Prothena Corp position peaked at $1K in Q2 2016.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on JFS Wealth Advisors's 13F filing for Q2 2024, filed 15 Jul 2024.